NIH Funding Opportunities (Notices, PA, RFA)

Syndicate content
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 12 hours 42 min ago

Request for Information (RFI): Strategies for Enhancing Postdoctoral Career Transitions to Promote Faculty Diversity

May 24, 2018 - 11:39am
Notice NOT-GM-18-034 from the NIH Guide for Grants and Contracts
Categories: NIH

Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R41/R42 - Clinical Trial Optional)

May 24, 2018 - 9:52am
Funding Opportunity PAR-18-802 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (STTR) grant applications from small business concerns (SBCs) proposing commercially-directed research for the development of cancer prevention, diagnosis, or treatment technologies to improve cancer outcomes in low- and middle-income countries (LMICs), and low-resource settings in the US. Specifically, the FOA solicits encourages grant applications from SBCs to develop or adapt, apply, and validate existing or emerging technologies into user-friendly products for cancer prevention, diagnosis, or treatment in low-resource settings. These technologies should be practical and affordable in the low-resource settings, including remote or underserved populations within or outside the US. The technologies may include, but are not limited to tools for vaccine dissemination/delivery, imaging, in vitro diagnosis, or treatment of pre-cancerous (pre-neoplastic) or cancerous lesions that are preventable or treatable within low-resource settings. Strong emphasis is placed on technologies that directly provide or immediately lead to treatment options available in the local health system.
Categories: NIH

Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional)

May 24, 2018 - 9:52am
Funding Opportunity PAR-18-801 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) proposing commercially-directed research for the development of cancer prevention, diagnosis, or treatment technologies to improve cancer outcomes in low- and middle-income countries (LMICs), and low-resource settings in the US. Specifically, the FOA solicits encourages grant applications from SBCs to develop or adapt, apply, and validate existing or emerging technologies into user-friendly products for cancer prevention, diagnosis, or treatment in low-resource settings. These technologies should be practical and affordable in the low-resource settings, including remote or underserved populations within or outside the US. The technologies may include, but are not limited to tools for vaccine dissemination/delivery, imaging, in vitro diagnosis, or treatment of pre-cancerous (pre-neoplastic) or cancerous lesions that are preventable or treatable within low-resource settings. Strong emphasis is placed on technologies that directly provide or immediately lead to treatment options available in the local health system.
Categories: NIH

NIOSH Exploratory/Developmental Grant Program (R21)

May 24, 2018 - 4:48am
Funding Opportunity PAR-18-798 from the NIH Guide for Grants and Contracts. The purpose of this grant program is to develop an understanding of the risks and conditions associated with occupational diseases and injuries, to explore methods for reducing risks and preventing or minimizing exposure to hazardous conditions in the workplace, and to translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries. NIOSH sponsors exploratory and developmental research projects by providing support for the early and conceptual stages of projects. Applicants must concisely describe the occupational health burden(s) being addressed in their proposal while also linking the need for the proposed research activities to planned outputs that will help address or alleviate this burden. Applicants should clearly articulate the anticipated impacts of the proposed research, both during the project period and beyond.
Categories: NIH

K01 Mentored Research Scientist Development Award

May 24, 2018 - 4:45am
Funding Opportunity PAR-18-799 from the NIH Guide for Grants and Contracts. The purpose of the K01 grant program is to provide support and dedicated time for a supervised (mentored) career development experience in occupational safety and health research, leading to research independence. This grant program also is to help ensure the availability of adequate numbers of highly trained scientists and educators to address critical issues in occupational safety and health.
Categories: NIH

NIOSH Small Research Grant Program

May 24, 2018 - 4:42am
Funding Opportunity PAR-18-797 from the NIH Guide for Grants and Contracts. The purpose of this grant program is to develop an understanding of the risks and conditions associated with occupational diseases and injuries, to explore methods for reducing risks and preventing or minimizing exposure to hazardous conditions in the workplace, and to translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries. The NIOSH R03 grant mechanism supports small occupational safety and health research projects that can be carried out with limited resources such as pilot and feasibility studies, secondary data analysis or development of research methods.
Categories: NIH

Notice for the All of Us Research Program Genome Centers (OT2) Funding Announcement and Informational Webinar

May 23, 2018 - 1:31pm
Notice NOT-PM-18-003 from the NIH Guide for Grants and Contracts
Categories: NIH

Biomarkers Discovery In Parkinsonism (U01 Clinical Trial Optional)

May 23, 2018 - 1:24pm
Funding Opportunity PAR-18-800 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to support hypothesis-driven research to discover human biomarkers in Parkinsons disease and other Parkinsonian syndromes, as a component of the NINDS Parkinsons Disease Biomarkers Program (PDBP). This FOA encourages biomarkers discovery projects in 1) genetically causal Parkinson's disease, especially for particular sub-types of Parkinson's Disease (PD), including genetic cohorts, biologically defined cohorts of idiopathic PD, or ethnic subgroups of idiopathic PD; 2) The differentiation of synucleinopathies (such as PD and Multiple System Atrophy (MSA) from tauopathies (such as Progressive Supranuclear Palsy and Corticobasal degeneration); or 3) to improve diagnostic differentiation between idiopathic/subtypes of PD and these disorders, as well as from Essential tremor. In order to further advance research in this area, broad sharing of biospecimens and associated data is a critical feature of the PDBP generally and of this FOA specifically. A timeline including milestones, which will be used to evaluate the application not only in peer review but also in consideration of the awarded project for funding of non-competing award years, is required for all studies.
Categories: NIH

NIH Directors Transformative Research Award (R01 - Clinical Trial Optional)

May 23, 2018 - 12:27pm
Funding Opportunity RFA-RM-18-009 from the NIH Guide for Grants and Contracts. The NIH Director's Transformative Research Award supports individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original, and/or unconventional research with the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies. Applications from individuals with diverse backgrounds and in any topic relevant to the broad mission of NIH are welcome. Little or no preliminary data are expected. Projects must clearly demonstrate the potential to produce a major impact in a broad area of biomedical or behavioral research. The NIH Directors Transformative Research Award is a component of the High-Risk, High-Reward Research program of the NIH Common Fund.
Categories: NIH

Findings of Research Misconduct

May 23, 2018 - 12:18pm
Notice NOT-OD-18-186 from the NIH Guide for Grants and Contracts
Categories: NIH

NIH Directors New Innovator Award Program (DP2 - Clinical Trial Optional)

May 23, 2018 - 2:30am
Funding Opportunity RFA-RM-18-008 from the NIH Guide for Grants and Contracts. The NIH Directors New Innovator Award supports early stage investigators of exceptional creativity who propose highly innovative new research approaches with the potential to produce a major impact on broad, important problems in biomedical or behavioral research. Applications from individuals with diverse backgrounds and in any topic relevant to the broad mission of NIH are welcome. The NIH Director's New Innovator Award complements ongoing efforts by NIH and its Institutes and Centers to fund early stage investigators through R01 grants, which continue to be the major sources of NIH support for early stage investigators. The NIH Directors New Innovator Award is a component of the High-Risk, High-Reward Research program of the NIH Common Fund.
Categories: NIH

Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)

May 22, 2018 - 1:29pm
Funding Opportunity PAR-18-796 from the NIH Guide for Grants and Contracts. NLM wishes to accelerate the availability of and access to secure, complete data sets and computational models that can serve as the basis of transformative biomedical discoveries by improving the speed and scope of the curation processes.
Categories: NIH

AHRQ Small Research Grant Program (R03)

May 21, 2018 - 12:49pm
Funding Opportunity PA-18-794 from the NIH Guide for Grants and Contracts. This FOA encourages Small Research Grant (R03) applications, and expresses AHRQ priority areas of interest for ongoing small research projects. The R03 grant mechanism supports different types of health services research projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.
Categories: NIH

AHRQ Health Services Research Demonstration and Dissemination Grants (R18)

May 21, 2018 - 12:34pm
Funding Opportunity PA-18-793 from the NIH Guide for Grants and Contracts. The Research Demonstration and Dissemination Grant (R18) is an award made by AHRQ to an institution/organization to support a discrete, specified health services research project. The project will be performed by the named investigator and study team. The R18 research plan proposed by the applicant institution/organization must be related to the mission and priority research interests of AHRQ.
Categories: NIH

AHRQ Health Services Research Projects (R01)

May 21, 2018 - 12:21pm
Funding Opportunity PA-18-795 from the NIH Guide for Grants and Contracts. The Research Project Grant (R01) is an award made by AHRQ to an institution/organization to support a discrete, specified health services research project. The project will be performed by the named investigator and study team. The R01 research plan proposed by the applicant institution/organization must be related to the mission and priority research interests of AHRQ
Categories: NIH

Advancing Evidence into Practice through Shared, Interoperable Clinical Decision Support Resources (U18)

May 21, 2018 - 12:08pm
Funding Opportunity PA-18-792 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites U18 cooperative agreement applications for innovative research on disseminating evidence into practice through shared, interoperable clinical decision support (CDS) resources.
Categories: NIH